{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T05:25:04Z","timestamp":1776489904571,"version":"3.51.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.vaccine.2022.10.025","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T03:22:26Z","timestamp":1666236146000},"page":"6917-6923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Where are children ages 5\u201317 years receiving their COVID-19 vaccinations? Variations over time and by sociodemographic characteristics, United States"],"prefix":"10.1016","volume":"40","author":[{"given":"Tammy A.","family":"Santibanez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla L.","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara M.","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Chatham-Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica P.","family":"Lendon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Singleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.10.025_b0005","unstructured":"Lu PJ, Santibanez TA, Williams WW, Zhang J, Ding H, Bryan L, et al. Surveillance of influenza vaccination coverage--United States, 2007-08 through 2011-12 influenza seasons. Morbidity and mortality weekly report Surveillance summaries (Washington, DC : 2002). 2013;62:1-28."},{"issue":"10","key":"10.1016\/j.vaccine.2022.10.025_b0010","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.vaccine.2016.01.032","article-title":"Place of influenza vaccination among children\u2013United States, 2010\u201311 through 2013\u201314 influenza seasons","volume":"34","author":"Santibanez","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.10.025_b0015","unstructured":"CDC. ACIP Meeting, June 23, 2022 Presentation, Evidence to Recommendation Framework, Sara Oliver. 2022."},{"issue":"50","key":"10.1016\/j.vaccine.2022.10.025_b0020","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.15585\/mmwr.mm6950e2","article-title":"The advisory committee on immunization practices' interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine - United States, December 2020","volume":"69","author":"Oliver","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"20","key":"10.1016\/j.vaccine.2022.10.025_b0025","doi-asserted-by":"crossref","first-page":"749","DOI":"10.15585\/mmwr.mm7020e1","article-title":"The advisory committee on immunization practices' interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12\u201315 Years - United States, May 2021","volume":"70","author":"Wallace","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2022.10.025_b0030","doi-asserted-by":"crossref","first-page":"859","DOI":"10.15585\/mmwr.mm7126e2","article-title":"Interim recommendations of the advisory committee on immunization practices for use of Moderna and Pfizer-BioNTech COVID-19 vaccines in children aged 6 months-5 years - United States, June 2022","volume":"71","author":"Fleming-Dutra","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2022.10.025_b0035","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.15585\/mmwr.mm7045e1","article-title":"The advisory committee on immunization practices' interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in children aged 5\u201311 years - United States, November 2021","volume":"70","author":"Woodworth","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2022.10.025_b0040","unstructured":"CDC. COVIDVaxView."},{"key":"10.1016\/j.vaccine.2022.10.025_b0045","unstructured":"CDC. COVID Data Tracker; 2021."},{"key":"10.1016\/j.vaccine.2022.10.025_b0050","unstructured":"CDC. About the National Immunization Surveys (NIS); 2019."},{"key":"10.1016\/j.vaccine.2022.10.025_b0055","unstructured":"Wolter KK, Smith PJ, Khare M, Welch B, Copeland KR, Pineau VJ, et al. Statistical Methodology of the National Immunization Survey, 2005-2014. Vital and health statistics Ser 1, Programs and collection procedures. 2017:1-107."},{"key":"10.1016\/j.vaccine.2022.10.025_b0060","unstructured":"CDC. CDC\/ATSDR Social Vulnerability Index. 2022."},{"key":"10.1016\/j.vaccine.2022.10.025_b0065","first-page":"28","article-title":"Disparities in first dose COVID-19 vaccination coverage among children 5\u201311 years of age, United States","author":"Murthy","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2022.10.025_b0070","doi-asserted-by":"crossref","first-page":"378","DOI":"10.15585\/mmwr.mm7110a4","article-title":"COVID-19 vaccine provider access and vaccination coverage among children aged 5\u201311 Years - United States, November 2021-January 2022","volume":"71","author":"Kim","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2022.10.025_b0075","unstructured":"CDC. Place of flu vaccination, children, United States, 2018-19 season; 2019."},{"key":"10.1016\/j.vaccine.2022.10.025_b0080","unstructured":"CDC. The Federal Retail Pharmacy Program for COVID-19 Vaccination; 2022."},{"key":"10.1016\/j.vaccine.2022.10.025_b0085","unstructured":"HHS. Public Readiness and Emergency Preparedness Act; 2020."},{"key":"10.1016\/j.vaccine.2022.10.025_b0090","unstructured":"(NASPA) APAAaNAoSPA. Pharmacist Administered Vaccines, January 2019, Based on APhA\/NASPA Survey."},{"key":"10.1016\/j.vaccine.2022.10.025_b0095","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.acap.2017.04.010","article-title":"The medical home at 50: are children with medical complexity the key to proving its value?","volume":"17","author":"Lerner","year":"2017","journal-title":"Acad Pediatr"},{"key":"10.1016\/j.vaccine.2022.10.025_b0100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1542\/peds.2004-1058","article-title":"The association between having a medical home and vaccination coverage among children eligible for the vaccines for children program","volume":"116","author":"Smith","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.10.025_b0105","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10995-013-1315-9","article-title":"A systematic review of the medical home for children without special health care needs","volume":"18","author":"Hadland","year":"2014","journal-title":"Matern Child Health J"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2022.10.025_b0110","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1542\/peds.2007-1115C","article-title":"Delivering adolescent vaccinations in the medical home: a new era?","volume":"121","author":"Szilagyi","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.10.025_b0115","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1542\/peds.112.4.821","article-title":"Potential burden of universal influenza vaccination of young children on visits to primary care practices","volume":"112","author":"Szilagyi","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.10.025_b0120","doi-asserted-by":"crossref","unstructured":"Santibanez TA, Lu PJ, O'Halloran A, Meghani A, Grabowsky M, Singleton JA. Trends in childhood influenza vaccination coverage--U.S., 2004-2012. Public health reports (Washington, DC : 1974). 2014;129:417-27.","DOI":"10.1177\/003335491412900505"},{"key":"10.1016\/j.vaccine.2022.10.025_b0125","unstructured":"CDC. Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States. 2022."},{"key":"10.1016\/j.vaccine.2022.10.025_b0130","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1056\/NEJMp2102535","article-title":"Mass-Vaccination Sites - An Essential Innovation to Curb the Covid-19 Pandemic","volume":"384","author":"Goralnick","year":"2021","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.vaccine.2022.10.025_b0135","unstructured":"CDC. Special considerations for COVID-19 SLV (C-SLV). 2021."},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2022.10.025_b0140","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1542\/peds.2011-0737K","article-title":"Epilogue: school-located influenza vaccination during the 2009\u20132010 pandemic and beyond","volume":"129","author":"Vogt","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.10.025_b0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40545-020-00291-7","article-title":"Geographical accessibility of medicines: a systematic literature review of pharmacy mapping","volume":"14","author":"Tharumia Jagadeesan","year":"2021","journal-title":"J Pharm Policy Pract"},{"key":"10.1016\/j.vaccine.2022.10.025_b0150","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.japh.2022.01.013","article-title":"Rural community pharmacists' ability and interest in administering COVID-19 vaccines in the Southern United States","volume":"62","author":"Carpenter","year":"2022","journal-title":"J Am Pharm Assoc: JAPhA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22012828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22012828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:18:52Z","timestamp":1759403932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22012828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":30,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0264410X22012828"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Where are children ages 5\u201317 years receiving their COVID-19 vaccinations? Variations over time and by sociodemographic characteristics, United States","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}